Gene · 6424
Papers2,245
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,245
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DSE inhibits melanoma progression by regulating tumor immune cell infiltration and VCAN. | Cell Death Discov | 2023 | 37833287 | PubTator, text mining | PubMed |
| ATNC: Versatile Nanobody Chimeras for Autophagic Degradation of Intracellular Unligandable and Undruggable Proteins. | J Am Chem Soc | 2023 | 37826913 | PubTator, text mining | PubMed |
| A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis. | Heliyon | 2023 | 37809372 | PubTator, text mining | PubMed |
| New insight into the role of fibroblasts in the epithelial immune microenvironment in the single-cell era. | Front Immunol | 2023 | 37809065 | PubTator, text mining | PubMed |
| Fluid flow shear stress and tissue remodeling-an orthodontic perspective: evidence synthesis and differential gene expression network analysis. | Front Bioeng Biotechnol | 2023 | 37795174 | PubTator, text mining | PubMed |
| The role of dexamethasone in mediating the contradictory effects of Wnt antagonists SFRP2 and SFRP3 on human hair follicle growth. | Sci Rep | 2023 | 37783752 | PubTator, text mining | PubMed |
| Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress. | Int J Biol Sci | 2023 | 37781032 | PubTator, text mining | PubMed |
| A combined clinical and specific genes' model to predict live birth for in vitro fertilization and embryo transfer patients. | BMC Pregnancy Childbirth | 2023 | 37777726 | PubTator, text mining | PubMed |
| Advances of autoimmune rheumatic diseases related to malignant tumors. | Inflamm Res | 2023 | 37768354 | PubTator, text mining | PubMed |
| Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression. | Cancer Discov | 2023 | 37768068 | PubTator, text mining | PubMed |
| A self-management app to improve asthma control in adults with limited health literacy: a mixed-method feasibility study. | BMC Med Inform Decis Mak | 2023 | 37759184 | PubTator, text mining | PubMed |
| Alterations in SAMD9, AHSG, FRG2C, and FGFR4 Genes in a Case of Late-Onset Massive Tumoral Calcinosis. | AACE Clin Case Rep | 2023 | 37736313 | PubTator, text mining | PubMed |
| A CCL2+DPP4+ subset of mesenchymal stem cells expedites aberrant formation of creeping fat in humans. | Nat Commun | 2023 | 37730641 | PubTator, text mining | PubMed |
| Transcriptional expression, prognostic value and immune infiltration of SFRP family in colorectal cancer: a study based on comprehensive bioinformatics and in vitro analyses. | Transl Cancer Res | 2023 | 37701102 | PubTator, text mining | PubMed |
| Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics. | Cancers (Basel) | 2023 | 37686633 | PubTator, text mining | PubMed |
| Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer. | Jpn Dent Sci Rev | 2023 | 37680614 | PubTator, text mining | PubMed |
| Inhibition of FNDC1 suppresses gastric cancer progression by interfering with Gβγ-VEGFR2 complex formation. | iScience | 2023 | 37670789 | PubTator, text mining | PubMed |
| CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects. | Sci Rep | 2023 | 37658225 | PubTator, text mining | PubMed |
| Rational design of small-molecule responsive protein switches. | Protein Sci | 2023 | 37656809 | PubTator, text mining | PubMed |
| Evolution of termination codons of proteins and the TAG-TGA paradox. | Sci Rep | 2023 | 37653005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6424/papers?page=12